Key takeaways of this white paper:
- Declining levels of NAD+ have been correlated with the body’s reduced capacity to perform many processes and functions fundamental to healthy aging.
- Replenishing NAD+ with NMN has shown to be a promising therapeutic strategy to counter age associated diseases.
- Clinical and preclinical studies have demonstrated that NMN has beneficial pharmacological activity on multiple critical elements of health: chiefly, energy metabolism and physical activity, glucose tolerance and insulin sensitivity, cardiovascular and cognitive functions, and inflammation.
- NMN supplementation presents a significant opportunity to address the increasing personal, social and economic burdens attributable to the cost and morbidity of age-related diseases.